Yuanlin Xu
- Topics
- Erythrocyte Function and Pathophysiology (7 papers)Lymphoma Diagnosis and Treatment (5 papers)MicroRNA in disease regulation (3 papers)
- Cited by
- Cancer ResearchGeneticsImmunology
- Journals
- Advanced MaterialsSHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yuanlin Xu
29 papers receiving 707 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 324
- Cancer Research 162
- Materials Chemistry 141
- Biomedical Engineering 135
- Immunology 105
Countries citing papers authored by Yuanlin Xu
This map shows the geographic impact of Yuanlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanlin Xu more than expected).
Fields of papers citing papers by Yuanlin Xu
This network shows the impact of papers produced by Yuanlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanlin Xu. The network helps show where Yuanlin Xu may publish in the future.
Co-authorship network of co-authors of Yuanlin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yuanlin Xu. A scholar is included among the top collaborators of Yuanlin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanlin Xu. Yuanlin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy | 29 |
| 12 | 4 | |
| 13 | 73 | |
| 14 | 11 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 11 | |
| 18 | 52 | |
| 19 | 20 | |
| 20 | 19 |
About Yuanlin Xu
Yuanlin Xu is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 33 papers that have together received 715 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (162 citations), Genetics (58 citations) and Immunology (105 citations). Yuanlin Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shujun Yang, Shiyong Zhou, Huilai Zhang, Xihong Zhang, Xiufeng Hu, Peipei Zhang, Yanyan Liu, Xiuli An, Shijie Zhang and Huan Zhang. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.